First Time Loading...

Transmedics Group Inc
NASDAQ:TMDX

Watchlist Manager
Transmedics Group Inc Logo
Transmedics Group Inc
NASDAQ:TMDX
Watchlist
Price: 136.14 USD 2.79% Market Closed
Updated: May 16, 2024

Transmedics Group Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Transmedics Group Inc
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Transmedics Group Inc
NASDAQ:TMDX
Revenue
$296.9m
CAGR 3-Years
128%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.7B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Revenue
$21B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

Transmedics Group Inc
Revenue Breakdown

Breakdown by Geography
Transmedics Group Inc

Not Available

Breakdown by Segments
Transmedics Group Inc

Total Revenue: 241.6m USD
100%
Product: 176m USD
72.9%
Service Revenue: 65.6m USD
27.1%

See Also

What is Transmedics Group Inc's Revenue?
Revenue
296.9m USD

Based on the financial report for Mar 31, 2024, Transmedics Group Inc's Revenue amounts to 296.9m USD.

What is Transmedics Group Inc's Revenue growth rate?
Revenue CAGR 5Y
81%

Over the last year, the Revenue growth was 149%. The average annual Revenue growth rates for Transmedics Group Inc have been 128% over the past three years , 81% over the past five years .